Skip to main navigation
Quantum Si
  • Technology
    • Overview
    • Resources
  • Products
    • Overview
    • Platinum
    • Assay & Workflow
    • Cloud
    • Carbon
  • Leadership
  • Investors
    • News
    • Events and Presentations
    • Stock Information
    • Financials
    • Governance
    • Investor Resources
  • Careers
  • Contact
Select Page
h
    • Technology
      • Overview
      • Resources
    • Products
      • Overview
      • Platinum
      • Assay & Workflow
      • Cloud
      • Carbon
    • Leadership
    • Investors
      • News
      • Events and Presentations
      • Stock Information
      • Financials
      • Governance
      • Investor Resources
    • Careers
    • Contact

News Details

  • Overview
  • News
  • Events & Presentations
    Events Presentations
  • Stock Information
    Stock Quote & Chart Analyst Coverage Historic Price Lookup
  • Financials
    Quarterly Results Annual Reports SEC Filings
  • Governance
    Governance Highlights Executive Management Board of Directors Committee Composition
  • Investor Resources
    Investor FAQs Investor Email Alerts Investor Contact

Quantum-Si to Participate in the 43rd Annual Cowen Health Care Conference

February 17, 2023
PDF Version

GUILFORD, Conn.--(BUSINESS WIRE)--Feb. 17, 2023-- Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing CompanyTM, today announced that it will be participating in the 43rd Annual Cowen Health Care Conference taking place at the Boston Marriott Copley Place, Boston, MA on March 6-8, 2023.

Quantum-Si’s management will present on Tuesday, March 7, 2023 at 9:10 AM ET.

A live and archived webcast of the event will be available in the Investors section of the Quantum-Si website under Events & Presentations.

About Quantum-Si Incorporated

Quantum-Si, The Protein Sequencing CompanyTM, is focused on revolutionizing the growing field of proteomics. The Company's suite of technologies is powered by a first-of-its-kind semiconductor chip designed to enable next-generation single-molecule protein sequencing and digitize proteomic research in order to advance drug discovery and diagnostics beyond what has been possible with DNA sequencing. Learn more at www.quantum-si.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230217005072/en/

Investor Contact
Juan Avendano
ir@quantum-si.com

Media Contact
Michael Sullivan
media@quantum-si.com

Source: Quantum-Si Incorporated

  • Print Page
  • Email Alerts
  • RSS Feeds
  • Contact IR
h
© Copyright 2023 QuantumSi | All rights reserved.
Follow us
  • Facebook
  • Twitter
  • LinkedIn
  • Instagram
  • Youtube